Antitumor effect of avermectins (2004)

Peer-Reviewed Study · Drinyaev VA, Mosin VA, Kruglyak EB, Novik TS, Sterlina TS, Ermakova NV, Kublik LN, Levitman MKh, Shaposhnikova VV, Korystov YN · October 6, 2004

Drinyaev VA et al., 2004-10-06: An early anticancer paper: avermectin mixtures suppressed mouse ascites and solid tumours, in Russia.

It was shown for the first time that avermectins possess a pronounced antitumor action.

19

Drinyaev VA et al., 2004-10-06: An early anticancer paper: avermectin mixtures suppressed mouse ascites and solid tumours, in Russia. C9. Study type: animal (mice). N: not stated in the abstract. Country: Russia (NBC Farmbiomed, Moscow, with co-authors at the Institute of Theoretical and Experimental Biophysics, Pushchino). Drug: a mixture of naturally occurring aversectin C and avermectin B1 – not ivermectin itself. Route: most effective intraperitoneally. Comparator: untreated tumour-bearing controls; also tested on top of vincristine. As abstracted, 'with some administration regimens, avermectins suppressed the tumor growth by 70-80%'. Funder/conflicts: none stated in the record. Limit: avermectin, mouse data. Study type: animal.